About this trial
This study aims to evaluate the effectiveness of pelvic floor muscle exercise (PFME) on improving lower urinary tract symptoms (LUTS), postvoid residual volume (PVR), and quality of life in patients undergoing surgery for benign prostatic hyperplasia (BPH). Patients who undergo BPH-related procedures, such as TURP or HoLEP, often experience postoperative symptoms including urinary urgency, frequency, nocturia, dribbling, and voiding difficulty, which may negatively affect daily living. Pelvic floor muscle exercise is believed to enhance urethral sphincter function and pelvic floor support, thereby improving urinary control. This randomized study assigns participants to either an intervention group receiving PFME training or a control group receiving standard postoperative care. Differences in urinary outcomes between groups will be compared. The findings are expected to provide an accessible and cost-effective rehabilitation strategy to support postoperative recovery and quality of life.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Diagnosed with benign prostatic hyperplasia (BPH) and scheduled to undergo their first prostate surgery.
Able to communicate in Mandarin or Taiwanese.
Disqualifiers
Patients with prostate cancer, bladder tumors, or other concomitant urological diseases.
Patients with long-term indwelling urinary catheters or suprapubic cystostomy.
Patients currently participating in other urology-related clinical trials.
Trial design
Treatments tested in this trial
- pelvic floor muscle exercises